Half-year report · HY
6823.TEDINET S100X28N
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥27.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥39.7bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥39.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥38.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥32.6bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥31.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥30.1bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.4bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥380m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥968m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥520m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥749m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥398m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥117.77 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.27 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 82.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Environmental Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.6bn |
| Environmental Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.6bn |
| Environmental Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥87m |
| Medical Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥6.1bn |
| Medical Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥6.1bn |
| Medical Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥593m |
| Particle Countersreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Particle Countersreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Particle Countersreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥13.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥13.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Environmental Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| Environmental Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| Environmental Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥139m |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥401m |
| Particle Countersreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Particle Countersreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Particle Countersreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 490
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital surplus | Prior1YearInstant | 2488397000 | JPY |
| Capital surplus | InterimInstant | 2502752000 | JPY |
| Retained earnings | Prior1YearInstant | 22549374000 | JPY |
| Retained earnings | InterimInstant | 23483251000 | JPY |
| Treasury stock | Prior1YearInstant | -10728000 | JPY |
| Treasury stock | InterimInstant | -10728000 | JPY |
| Shareholders equity | Prior1YearInstant | 27091944000 | JPY |
| Shareholders equity | InterimInstant | 28054531000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 480787000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 622974000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | 3207031000 | JPY |
| Revaluation reserve for land | InterimInstant | 3207031000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -42443000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 6694000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 698452000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | 673695000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 4343827000 | JPY |
| Valuation and translation adjustments | InterimInstant | 4510395000 | JPY |
| Net assets | Prior1YearInstant | 31435771000 | JPY |
| Net assets | InterimInstant | 32564926000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 39132557000 | JPY |
| Liabilities and net assets | InterimInstant | 39665023000 | JPY |
| Net sales | Prior1InterimDuration | 13040586000 | JPY |
| Net sales | InterimDuration | 13621448000 | JPY |
| Cost of sales | Prior1InterimDuration | 6300262000 | JPY |
| Cost of sales | InterimDuration | 6807910000 | JPY |
| Gross profit | Prior1InterimDuration | 6740324000 | JPY |
| Gross profit | InterimDuration | 6813538000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 4978693000 | JPY |
| Selling general and administrative expenses | InterimDuration | 4828570000 | JPY |
| Operating income | Prior1InterimDuration | 1761630000 | JPY |
| Operating income | InterimDuration | 1984967000 | JPY |
| Interest income noi | Prior1InterimDuration | 4407000 | JPY |
| Interest income noi | InterimDuration | 3067000 | JPY |
| Dividends income noi | Prior1InterimDuration | 24846000 | JPY |
| Dividends income noi | InterimDuration | 33864000 | JPY |
| House rent income noi | Prior1InterimDuration | 20757000 | JPY |
| House rent income noi | InterimDuration | 20002000 | JPY |
| Other noi | Prior1InterimDuration | 19117000 | JPY |
| Other noi | InterimDuration | 19688000 | JPY |
| Non operating income | Prior1InterimDuration | 69129000 | JPY |
| Non operating income | InterimDuration | 76623000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 1077000 | JPY |
| Interest expenses noe | InterimDuration | 1234000 | JPY |
| Foreign exchange losses noe | Prior1InterimDuration | 3362000 | JPY |
| Foreign exchange losses noe | InterimDuration | 2528000 | JPY |
| Commission fee noe | Prior1InterimDuration | 21139000 | JPY |
| Commission fee noe | InterimDuration | 23446000 | JPY |
| Other noe | Prior1InterimDuration | 2548000 | JPY |
| Other noe | InterimDuration | 2450000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |